Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07022496
PHASE4

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Sponsor: Ain Shams University

View on ClinicalTrials.gov

Summary

Caffeine extracted from green tea to abort acute attack of Migraine

Official title: Assessment of Oral Caffeine Intake in Reducing the Severity of Acute Migraine Attack Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2023-04-26

Completion Date

2025-08

Last Updated

2025-06-15

Healthy Volunteers

No

Interventions

DRUG

Caffeine (200 mg)

caffeine tablets

DRUG

triptans

Sumatriptan

DRUG

NSAID (Nonsteroidal anti-inflammatory drugs)

Aspirin 250 mg, 81 mg, 75 mg

DRUG

Paracetamol (acetaminophen)

Paracetamol 250 mg

Locations (1)

Ainshams university

Cairo, Egypt